| |
Hypertensive BP at baseline (n=30)
|
Normotensive BP at baseline (n=191)
|
Hypertensive BP at follow up (n=131)
|
Normotensive BP at follow up (n=90)
|
|---|
|
Minority race % (n)
|
77 (23)
|
64 (121)
|
69.4 (91)
|
60 (53)
|
|
Renal disease % (n)
|
57 (17)
|
41 (77)
|
49.6 (65)
|
32.6 (29)
|
|
Proliferative LN % (n)
|
23 (7)
|
26 (50)
|
33.6 (44)
|
19 (17)
|
|
Mean BMI kg/m2 (SD)
|
26.3 (6.3)
|
24 (5.1)
|
25.2 (5.7)
|
23.2 (4.4)
|
|
Mean duration of SLE, months
|
27.6
|
31.7
|
33.6
|
26.7
|
|
ACEI ever
|
60 (18)
|
36 (69)
|
44 (58)
|
31 (28)
|
- Characteristics of patients with hypertension at baseline and follow up within the APPLE cohort
